




A 3D collagen hydrogels stem cell tissue engineered formulation basing on growth factor phospholipid complex loaded PHBHHx nanoparticles
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Abstract: This study aimed to design a growth factor loaded copolyester of 3-hydroxybutyrate and 3-hydroxyhexanoate (PHBHHx) nanoparticles containing 3D collagen matrix to achieve growth factor sustained release for long-term stimulation of human mesenchymal stem cells (hMSCs) proliferation/differentiation for tissue engineer application. Platelet derived growth factor-BB (PDGF-BB), which is known to enhance hMSCs proliferation in human serum, was selected as a model growth factor, and biodegradable copolyester of PHBHHx was chosen to be the sustained release vehicle. PDGF-BB phospholipid complex encapsulated PHBHHx nanoparticles were fabricated, and their effect on hMSCs proliferation was investigated via assays of CCK-8 and live-dead staining to cells inoculated in 2D tissue culture plates and 3D collagen gel scaffolds, respectively. The resulting spherical PHBHHx nanoparticles were stable in terms of their mean particle size, polydispersity index and zeta potential before and after lyophilization. In vitro study revealed a sustained release of PDGF-BB with a low burst release. Furthermore, sustain released PDGF-BB was revealed to significantly promote hMSCs proliferation in both cell monolayer and cell seeded 3D collagen scaffolds inoculated in serum-free media. Therefore, the 3D collagen matrices with locally sustained release growth factor nanoparticles hold promise to be used for stem cell tissue engineering.












Bone marrow mesenchymal stem cells (MSCs) are considered to be one of the most promising cell types in the field of tissue engineering 1. MSCs have been shown to differentiate into a number of cell types such as osteoblasts, chondrocytes, adipocytes, as well as muscle cells 2-4, and it is known that culture conditions and growth factors are essential factors for the control of their differentiation and proliferation 5,6. Growth factors have been shown to be powerful regulators with biological function, and their presence in MSCs is highly regulated in both time and spatial cues 7,8. However, the rapid inactivation and extremely short plasma half-life of the growth factors prevent their sustained effect 9. It is therefore essential to develop a carrier system to maintain growth factors at an effective concentration for a longer period, which potentially can direct MSCs differentiation spatially in a 3D environment 10-11. 
Among the possible strategies to achieve sufficient bioavailability of growth factors, nanoparticle carriers made from biodegradable polymers represent an exciting approach to improve the transport of growth factors and its subsequent initiation of a cellular response 12-14. Compared with other colloidal carriers, such as submicron emulsions and liposomes, biodegradable polymeric nanoparticles offer a higher stability when they are in contact with biological fluids 15,16. The polymeric nature of nanoparticle also protects the growth factors from adverse external conditions and controls their release during the polymer degradation process 17. 
Poly-3-hydroxybutyrate-co-3-hydroxyhexanoate (PHBHHx), including its other members of polyhydroxyalkanoates (PHA) biopolyester family, has been extensively studied as a tissue engineering biomaterial and considered to be a very promising biomaterial due to its total biodegradability, non-toxic, non-immunogenic degradation products and better elastic properties 18-23. PHBHHx was ever used as a biodegradable nanoparticle carrier for sustained release of hydrophobic drugs due to its hydrophobic ester backbone and alkane side chain 24,25. However, most growth factors are hydrophilic proteins and this poses a significant challenge to encapsulating not hydrophobic protein into hydrophobic PHBHHx nanoparticles efficiently. In a previous study, Peng et al 26 and his group developed an attractive way to improve the liposolubility of water-soluble protein with a higher entrapment efficiency by formation of a drug phospholipid complex, which is consistent with the results reported by Cui et al 12.
Thermo-sensitive collagen hydrogel is a free-flowing liquid under room temperature and can form a non-free-flowing gel at 37oC 27. Based on its solution to gel transition property and favorable biological characteristics (i.e., biocompatibility, biodegradability), the thermo-sensitive hydrogel has been widely studied as a 3D tissue engineer scaffold.




PHBHHx [Poly(R-3-hydroxybutyrate-co-12 mol% R-3-hydroxyhexanoate)] was supplied by Lukang Group (Shandong, China). Recombinant human PDGF-BB was purchased from Peprotech (NJ, USA). Human PDGF-BB quantikine ELISA kit was bought from R&D systems (UK). DMEM containing high glucose, L-glutamine, non-essential amino acids (NEAA), and phosphate buffered saline (PBS), were purchased from Lonza (Switzerland). Rat tail collagen type I was provided by BD Biosciences (UK). Cell Counting Kit-8 (CCK-8) was supplied by Dojindo (Japan). Live-dead cell double staining kit, l-α-phosphatidylcholine, poloxamer 188 (F68), sodium deoxycholate, acetic acid, dimethyl sulfoxide (DMSO) and chloroform were purchased from Sigma Aldrich (SL, USA). All other chemical reagents were analytical grade or better (Sigma Aldrich, USA).
Fabrication of PHBHHx nanoparticles 
PHBHHx nanoparticles were prepared based on a method reported previously 26 with some modifications. PDGF-BB and l-α-phosphatidylcholine were co-dissolved in DMSO containing 1.25% glacial acetic acid under magnetic stirring at 30°C, then freeze-dried overnight to obtain PDGF-BB phospholipid complex (PDGF-PLC). PHBHHx and PDGF-PLC were dissolved or dispersed in chloroform at a weight ratio of 80:1. Subsequently, an aqueous solution containing 0.5% F68 and 0.5% sodium deoxycholate was added to the organic solution with a volume ratio of 20:1, and followed by sonication in an ice-water bath to form a stable o/w emulsion. A homogeneous fresh nanoparticles suspension was obtained after chloroform evaporation. Before storage, 10% maltose was dissolved in nanoparticles suspension. The mixture was frozen at -80°C overnight followed by lyophilization for 48 h. Blank NPs and BSA NPs were prepared as controls using the same protocol.
Physicochemical characterization of PHBHHx nanoparticles
The mean particle size, distribution and zeta potential of the resulted PHBHHx nanoparticle suspension were studied using a Zetasizer 3000 HSA (Malvern Instruments Ltd., U.K.) at 25°C. The particle size was evaluated based on the intensity distribution, which was evaluated by polydispersity index (PDI). After re-dispersion in distilled water, the lyophilized PHBHHx nanoparticle suspension was measured via the same parameters as fresh nanoparticles.
The morphology of PHBHHx nanoparticles was observed using a Scanning Electron Microscope (Hitachi S4500) (Japan) at an accelerating voltage of 5 kV. One drop of the resulted PDGF NPs suspension was placed on a glass surface. After an air drying process, the sample was coated with gold using an Ion Sputter.
Encapsulation efficiency of PHBHHx nanoparticles
Briefly, 0.5 ml the resulted PDGF NPs suspension was mixed with 0.5 ml 0.05 M NaOH. The mixture was stirred for 24 h at room temperature so that the PHBHHx nanoparticles could be degraded by alkaline hydrolysis. The resultant sample was analyzed by ELISA kit after proper dilution. As a result the total added amount of PDGF-BB (Wt) was obtained. Meanwhile, another 0.5 ml PDGF NPs suspension was taken, and mixed with 0.5 ml dH2O. The sample was also analyzed by ELISA kit after proper dilution. As such the amount of non-encapsulated PDGF-BB (Wn) was obtained. Therefore, the encapsulation efficiency could be calculated according to the following equation:
EE = (Wt - Wn) / Wt × 100%
In vitro release kinetic of PDGF-BB from PDGF NPs
PDGF-BB release profile was measured using the dialysis tube (Spectrum Labs) with 100 kDa molecular weight cut off, which keeps PDGF NPs in and allows the released PDGF-BB out of the tube. After 1 ml PDGF NPs suspension was transferred into a dialysis tube, the sample loaded dialysis tube was soaked in 6 ml dH2O at room temperature under magnetic stirring. At predetermined time intervals the dH2O outside the dialysis tube was withdrawn completely and replaced with 6 ml fresh dH2O. The collected samples were diluted into 10 ml then stored at -80°C for ELISA kit analysis.
Optimization of PDGF-BB concentration for hMSCs proliferation
Primary human mesenchymal stem cells (Lonza) were employed to investigate optimal PDGF-BB concentration to promote hMSCs proliferation in vitro. hMSCs (passage 3-5) were plated in 96-well plates with a cell density of 4×103 cells per well, and cultured for 24 h on a full serum medium (DMEM supplemented with 5% fetal bovine serum, 1% L-glutamine and 1% NEAA). Then followed by 24 h culture in serum free medium (DMEM supplemented with 1% L-glutamine and 1% NEAA). PDGF-BB was supplemented at final concentrations of 0, 5, 10, and 25 ng/ml, respectively, with 1% NEAA and 1% L-glutamine in DMEM media. At multiple time points, cell proliferation was evaluated using the CCK-8 assay.
Effect of sustained released PDGF-BB on hMSCs proliferation in 2D cell culture system
hMSCs were seeded in 6-well plates at the density of 5×104 cells per well, and cultured for 2 days with a full serum medium to reach about 50% confluence. Then followed by 24 h culture in serum free medium. hMSCs were incubated in sterile PDGF NPs contained serum-free media. Cell viability was measured using CCK-8 kit after culturing for 2 and 4 days, respectively. Cells cultured in BSA NPs, blank NPs and no NPs contained media were used as controls.
Effect of sustained released PDGF-BB on hMSCs proliferation in cell seeded 3D collagen hydrogels
hMSCs were seeded in T75 flasks, then cultured for 3 days with the full serum medium, followed by 24 h culture in serum free medium. After the trypsinizing treatment, hMSCs suspension in DMEM media, sterile 10×DMEM, sterile concentrated PDGF NPs suspension, sterile 1 M NaOH, and rat tail collagen, were combined according to the BD Biosciences (UK) manufacturer’s instructions in ice bath to produce a final concentration of 2×105 cells/ml in 0.5 mg/ml collagen gel. After mixing homogeneously by pipetting, a volume of approximately 400 µl was dispensed into 6-well plates. After incubation in 37oC for 30 min, the collagen scaffold was covered with serum-free DMEM media, and incubated in 37oC incubator. Cell viability was measured using CCK-8 kit after culturing 2 and 4 days, respectively. In addition, the overall cell morphology was monitored via a live-dead cell double staining kit using Nikon Eclipse T1 microscope fluorescence microscope (Japan) at day 2 and 4. Collagen scaffolds fabricated with BSA NPs, blank NPs and no NPs were used as controls.
Statistical analysis
All data was expressed as the mean ± standard deviation (SD). Statistical analysis was carried out using the unpaired Student’s t-test (Microsoft, Seattle, USA). P＜0.05 was considered to be statistically significant and P＜0.01 highly significant.

RESULTS
Characterization of PHBHHx nanoparticles before and after lyophilization
The properties of PHBHHx nanoparticles before and after lyophilization were studied and compared with their mean particle sizes, PDI, zeta potentials and encapsulation efficiencies (Table 1). Among the three types of PHBHHx nanoparticles, mean particle size and PDI slightly fluctuated, while PDGF NPs and BSA NPs had significantly higher zeta potential than that of the blank NPs. In addition, the lyophilized PHBHHx nanoparticles could be dispersed in distilled water and quickly re-formed to become a homogeneous nanoparticle suspension. Compared with fresh nanoparticles, lyophilized nanoparticles became slightly larger having a higher PDI value and lower zeta potential. Importantly, the lyophilization process did not lead to a significant change in encapsulation efficiency of PDGF NPs where a slight, but non-significant decrease from 82.97% to 74.63% was observed. These results indicated that the lyophilization process did not lead to a big change on properties of PHBHHx nanoparticles. Meanwhile, the PHBHHx nanoparticles, observed via SEM, were mostly spherical in shape and well distributed in size (Fig. 1).
In vitro release kinetic of PDGF-BB from PDGF NPs
Figure 2 showed the in vitro release profile of PDGF-BB from PDGF NPs obtained using a dynamic dialysis method. Over the 72 h course, the cumulative amounts of released PDGF-BB were almost 25%. Nearly 20% of encapsulated PDGF-BB was released during the initial 24 h, and about 5% release was observed in the late 48 h. Overall, a sustained release of PDGF-BB was achieved, and the optimal PDGF-BB concentration range could be achieved by varying of the amount of PDGF NPs in the further cell culture studies.
Optimization of PDGF-BB concentration for hMSCs proliferation
To determine the optimal working concentration range of PDGF-BB for hMSCs proliferation, viability of cells grown in four different concentrations (0, 5, 10 and 25 ng/ml) of PDGF-BB media was studied after 2, 4 and 6 days incubation, respectively (Fig. 3). In all cases, cells cultured in PDGF-BB media displayed improved viability when compared to the control group of cells cultured without PDGF-BB. Among three different concentrations, activities of cells cultured with 5 ng/ml and 10 ng/ml PDGF-BB were much better compared with 25 ng/ml PDGF-BB group (Fig. 3). These results suggested that the presence of PDGF-BB promoted hMSCs proliferation and 5-10 ng/ml had the most significant positive effect, while too high concentration (25 ng/ml) or negative control (0 ng/ml) was not inductive for hMSCs proliferation.
Effect of sustained released PDGF-BB on hMSCs proliferation in 2D cell culture system
Cell proliferation in monolayer 2D cell culture system was analyzed by CCK-8 assay. Primary hMSCs were used to evaluate cell proliferation in various nanoparticles containing media. After 2 days incubation, hMSCs cultured in PDGF NPs containing media showed the strongest increase in cell numbers compared with that in BSA NPs, blank NPs and no NPs ones (Fig. 4). Meanwhile, cells cultured in BSA NPs and blank NPs media were similar in number compared with the group cultured in no NPs contained media. After 4 days incubation, cell number increased significantly in PDGF NPs media, while little increase was observed in control groups (Fig. 4). It became clear that the presence of PDGF NPs in media improved hMSCs proliferation.
Effect of sustained released PDGF-BB on hMSCs proliferation in cell seeded 3D collagen hydrogels
After 2 and 4 days cultivation in 3D collagen scaffolds containing PDGF NPs, BSA NPs, blank NPs or no NPs, hMSCs were stained using a live-dead fluorescent double staining kit which is able to simultaneously stain viable cells green, and dead cells red. Although cell shapes in hydrogels could not be clearly observed under a fluorescence microscope, more green fluorescence was visible inside the PDGF NPs containing collagen scaffolds than that of BSA NPs, blank NPs and no NPs containing scaffolds, respectively (Fig. 5). In addition, green fluorescence was observed to become more intensive and widely distributed on day 4 compared with that on day 2, especially in the PDGF NPs containing scaffolds. This phenomenon suggests that PDGF NPs sustained release system was more effective in promoting cell proliferation than the controls outlined above.
CCK-8 assay was employed to compare hMSCs viability in various nanoparticles containing collagen gels. The highest cell viability was observed in PDGF NPs containing gels, while other groups were similarly lower in viability among BSA NPs, blank NPs and no NPs controls (Fig. 6). These results again demonstrated that sustained released PDGF-BB significantly promoted hMSCs proliferation in serum-free media.

DISCUSSION
It is a challenge to directly encapsulate hydrophilic protein into hydrophobic PHBHHx vehicle. Among the present encapsulation techniques used, w/o/w method represents a relatively simple and efficient way for entrapment of hydrophilic compounds 20. Nevertheless, the protein loading capacity of the carriers is reduced significantly due to the rapid migration and loss of drug into the external aqueous phase 20. Improving the liposolubility of hydrophilic protein is an attractive way to enhance their loading efficiency. Previous studies have shown that the lipophilicity of protein was significantly enhanced by the formation of protein phospholipid complex, and it was successfully used to fabricate a controlled release insulin nanoparticles 26,27. Based on this successful study, PDGF-BB was complexed with phospholipid by an anhydrous co-solvent lyophilization procedure, which led to the high encapsulation efficiency of PDGF-BB in the PDGF NPs system (Table 1).
To prepare PHBHHx nanoparticles loaded with growth factor, different parameters including polymer concentrations, polymer and drug solvents, as well as preparation temperatures were optimized to obtain nanoparticles with small particle sizes, low PDI value and high zeta potential, which indicated the fine stability of the prepared nanoparticle system (Table 1). Nevertheless, it is well known that the stable system would be destroyed due to oxidation of phospholipid, particle aggregation and/ or bacterial growth if nanoparticles were mainatianed in a suspension for a long time. Hence, lyophilization technique was applied to maintain the long-term stability of the nanoparticle system. As shown in Table 1, nanoparticles before and after lyophilization presented similar quality with a bit change possibly due to partial aggregation among nanoparticles.
Generally, there are two distinct release mechanisms of encapsulated proteins from nanoparticles or microspheres. Firstly, the initial minor rapid dissociation of surface-adsorbed proteins; secondly, a sustained release of proteins ruled by thermodynamic equilibrium 29. Many studies have reported that the encapsulated proteins show a significant fast release rate with an initial burst 30,31. One potential reason is the large amount of proteins absorbed on the surface of nanoparticles; another one is the faster degradability of materials. In this study, we have shown that there is a high degree of slow release by diffusion through the nanoparticle skeleton of PDGF-BB from PDGF NPs (Fig. 2). Meanwhile, a small degree of burst release was observed potentially due to the intensive washing process and the very slow degradability of PHBHHx at this relative short period.
It is well known that the attachment and spreading of cells can occur in serum containing environment since there are many cell attachment and proliferation factors in serum 32. Therefore, hMSCs were pretreated with serum free medium for 24 h before replacing the PDGF-BB containing media. In order to study the optimal PDGF-BB concentration working for hMSCs proliferation, serum free media was also selected with 0, 5, 10 and 25 ng/ml PDGF-BB, respectively (Fig. 3). 
In addition, since the PDGF NPs were composed of PDGF-BB, PHBHHx and l-α-phosphatidylcholine, blank NPs and BSA NPs were prepared as control groups. Meanwhile, nanoparticles free media or collagen scaffold were also selected as control groups in the cell culture study. As expected, cell viability in PDGF NPs containing environment, tested by CCK-8 assay (Fig. 4 & 6), was better than those in all control groups, demonstrating that released PDGF-BB from PDGF NPs improved hMSCs proliferation. More evidence was obtained by the live-dead cell double staining (Fig. 5). In this study, we have also demonstrated the use of PHBHHx nanoparticles to release growth factor in a 3D cell seeded collagen environment. The remarkable increase in cell number and viability implied the critical role of released PDGF-BB in hMSCs growth and proliferation in tissue engineering approaches. Using this technique, we can begin to spatially regulate cell differentiation within a complex tissue engineered organ.

CONCLUSIONS
PDGF-BB phospholipid complex loaded biodegradable PHBHHx nanoparticles fabricated by a solvent evaporation method was prepared for sustained release PDGF-BB in collagen hydrogel scaffolds. Meanwhile, BSA phospholipid complex loaded nanoparticles and blank nanoparticles were produced as controls. Physico-chemical characterization showed a small particle size, spherical shape, as well as high cytokines encapsulation efficiency. Lyophilized nanoparticles presented similar properties with the fresh ones. PDGF-BB released from PDGF NPs at a slow rate showed a slight burst release. Significantly, CCK-8 assay indicated a clearly positive effect of sustained release PDGF-BB on hMSCs proliferation regardless of whether the inoculation was in 2D tissue culture plates or in 3D collagen scaffolds. Additional live-dead fluorescent double staining assays further confirmed the CCK-8 results. It was concluded that growth factor phospholipid complex loaded PHBHHx nanoparticles was a convenient and effective approach for the sustained and controlled release of growth factors to stimulate stem cells growth, proliferation and differentiation in 3D collagen hydrogels. Therefore, the PHBHHx nanoparticle collagen hydrogel system is promising to serve as a 3D stem cell tissue engineering formulation.
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Table 1 Characterization of PHBHHx nanoparticles before and after lyophilization
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